Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Food Nutr Res. 2009;53. doi: 10.3402/fnr.v53i0.1842. Epub 2009 Mar 4.
Available reports on adherence to recommended guidelines for labeling of probiotic products are based on assessment of these products in developed countries. In the Arabian Gulf region, there is a paucity of data on the characterization of probiotic products and an absence of local guidelines for their labeling. This study, carried out in the United Arab Emirates (UAE), represents the first evaluation of probiotic products available in the Arabian Peninsula.
Probiotic products were purchased over the counter from a variety of sources, including pharmacies, healthfood stores, and supermarkets across the UAE. All identified products were listed and information regarding type of product preparation and labeling information were recorded.
A total of 37 probiotic products, 15 dairy-based and 22 non-dairy-based were identified. The dairy products comprised of 12 yogurts, two fermented milk products and one powdered baby formula. The majority of non-dairy products were in capsule form (n = 16). While all the non-dairy products gave information about the strain of probiotic microorganism and number present at time of manufacture, this information was provided for only one dairy-based product. Strains of Lactobacillus acidophilus were the most common probiotic organisms identified. However, one probiotic product listed Enterococcus faecalis (750 million viable bacteria per capsule) as a component. With the exception of one non-dairy-based product, all health-related claims were structure/function statements, according to the US Food and Drug Administration nomenclature.
These findings indicate that a wide variety of probiotic products are available in the Arabian Gulf. Development of guidelines for labeling of these probiotic products and use of structure/function statements and health claims should be addressed.
现有的关于益生菌产品标签建议指南遵循情况的报告是基于对发达国家这些产品的评估。在阿拉伯海湾地区,缺乏对益生菌产品特征的描述,也没有针对其标签的本地指南。本研究在阿拉伯联合酋长国(阿联酋)进行,代表了对阿拉伯半岛现有益生菌产品的首次评估。
从阿联酋各地的各种来源(包括药店、保健食品商店和超市)购买非处方益生菌产品。所有识别出的产品都被列出,并记录了产品制备类型和标签信息。
共确定了 37 种益生菌产品,其中 15 种是乳制品基的,22 种是非乳制品基的。乳制品产品包括 12 种酸奶、两种发酵乳产品和一种粉状婴儿配方奶粉。大多数非乳制品产品为胶囊形式(n=16)。虽然所有非乳制品产品都提供了有关益生菌微生物菌株和制造时存在数量的信息,但这一信息仅提供给一种乳制品产品。嗜酸乳杆菌是最常见的益生菌菌株。然而,有一种益生菌产品将粪肠球菌(每粒胶囊 7.5 亿个活菌)列为成分。除了一种非乳制品产品外,根据美国食品和药物管理局的命名法,所有与健康相关的声明都是结构/功能声明。
这些发现表明,在阿拉伯海湾地区有各种各样的益生菌产品可供选择。应该制定这些益生菌产品标签的指南,并使用结构/功能声明和健康声明。